• 1
    Ness RB, Sibai BM. Shared and disparate components of the pathophysiolgies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol. 2006;195:4049.
  • 2
    Surya P. National High Blood Pressure Education Program Working Group. Report on high blood pressure in pregnancy. Am J Obstet Gyncol. 1990;163:16891712.
  • 3
    Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension. 2008;51:960969.
  • 4
    Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens. 2008;2:484494.
  • 5
    Wolf M, Shah A, Jimenez-Kimble R, et al. Differential risk of hypertensive disorders of pregnancy among Hispanic women. J Am Soc Nephrol. 2004;15:13301338.
  • 6
    Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preelampsia in women at high risk. N Engl J Med. 1998;338:701705.
  • 7
    The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol. 2010;202:255.e1255.e7.
  • 8
    Garner PR, D’Alton ME, Dudley DK, et al. Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol. 1990;163:505508.
  • 9
    Hanson U, Persson B. Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden. Acta Obstet Gynecol Scand. 1998;77:620624.
  • 10
    Hiilesmaa V, Suhonen L, Teramo K. Glycaemic control is associated with preeclampsia but not with pregnancy-induced hypertension in women with Type 1 diabetes mellitus. Diabetologia. 2000;43:15341539.
  • 11
    Bond MJ, Umans JG. Microvascular complications and the diabetic pregnancy. Curr Diab Rep. 2006;6:291296.
  • 12
    Rosenn B, Miodovnik M, Combs CA, et al. Poor glycemic control and antepartum obstetric complications in women with insulin-dependent diabetes. Int J Gynaecol Obstet. 1993;43:2128.
  • 13
    Combs CA, Rosenn B, Kitzmiller JL, et al. Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol. 1993;82:802807.
  • 14
    Bar J, Ben-Rafael Z, Padoa A, et al. Prediction of pregnancy outcome in subgroups of women with renal disease. Clin Neprhol. 2000;53:437444.
  • 15
    Powers RW, Jeyabalan A, Clifton RG, et al. Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PIGF) in preeclampsia among high risk pregnancies. PLoS ONE. 2010;5:e13263.
  • 16
    Bryson CL, Ioannou GN, Rulyak SJ, et al. Association between gestational diabetes and pregnancy-induced hypertension. Am J Epidemiol. 2003;158:11481153.
  • 17
    Joffe GM, Esterlitz JR, Levine R, et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Am J Obstet Gynecol. 1998;179:10321037.
  • 18
    Ness R, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol. 2006;195:115.
  • 19
    Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88:23932398.
  • 20
    Barbour LA, McCurdy CE, Hernandez TL, et al. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30(Suppl 2):S112S119.
  • 21
    Solomon CG, Carroll JS, Okamura K, et al. Higher cholesterol and insulin levels are associated with increased risk for pregnancy-induced hypertension. Am J Hypertens. 1999;12:276282.
  • 22
    HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:19912002.
  • 23
    Lykke JA, Langhoff-Roos J, Sibai BM, et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53:944951.
  • 24
    Fuh MMT, Yin CS, Pei D, et al. Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy. Am J Hypertens. 1995;8:768771.
  • 25
    Laivori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab. 1996;81:29082911.
  • 26
    Parving HH, Andersen AR, Smidt UM, et al. Effect of antihypertensive treatment on kidney function in diabetic neprhopathy. Br Med J. 1987;294:14431447.
  • 27
    Ravid M, Savin H, Jutrin I, et al. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive Type II diabetic patients. Ann Intern Med. 2000;118:577581.
  • 28
    Quan A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev. 2006;82:2328.
  • 29
    Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354:24432500.
  • 30
    Lennestal R, Olausson PO, Kallen B. Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol. 2009;65:615625.
  • 31
    Nakhai-Pour HR, Rey E, Berard A. Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns. Birth Defects Res B Dev Reprod Toxicol. 2010;89:147154.
  • 32
    Caton AR, Bell EM, Druschel CM, et al. Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension. 2009;54:6370.
  • 33
    Biesenbach G, Stroger H, Zazgornik J. Influence of pregnancy on progression of diabetic nephropathy and subsequent requirement of renal replacement therapy in female type 1 diabetic patients with impaired renal function. Nephrol Dial Transplant. 1992;7:105109.
  • 34
    Purdy LP, Hantsch CE, Molitch ME, et al. Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. Diabetes Care. 1996;19:10671074.
  • 35
    Biesenbach G, Grafinger P, Zazgornik J, et al. Perinatal complications and three-year follow up of infants of diabetic mothers with diabetic nephropathy stage IV. Ren Fail. 2000;22:573580.
  • 36
    Khoury JC, Miodovnik M, LeMasters G, et al. Pregnancy outcome and progression of diabetic nephropathy. What’s next? J Matern Fetal Neonatal Med. 2002;11:238244.
  • 37
    Hod M, van Dijk DJ, Karp M, et al. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome. Nephrol Dial Transplant. 1995;10:23282333.
  • 38
    Bar J, Chen R, Schoenfeld A, et al. Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy. J Pediatr Endocrinol Metab. 1999;12:659665.
  • 39
    Martin JN, Thigpen BD, Moore RC, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005;105:246254.
  • 40
    Haddad B, Deis S, Goffinet F, et al. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks’ gestation. Am J Obstet Gynecol. 2004;190:15901597.
  • 41
    Budden A, Wilkinson L, Buksh MJ, et al. Pregnancy outcome in women presenting with pre-eclampsia at less than 25 weeks’ gestation. Aust N Z J Obstet Gynaecol. 2006;46:407412.
  • 42
    Abramovici D, Friedman SA, Mercer BM, et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks’ gestation: does HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome matter? Am J Obstet Gynecol. 1999;180:221225.
  • 43
    Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild preeclampsia after 36 weeks’ gestation (HYPITAT): a multi-centre, open-label randomized controlled trial. Lancet. 2009;374:979988.
  • 44
    Yankowitz J. Pharmacological treatment of hypertensive disorders during pregnancy. J Perinat Neonatal Nurs. 2004;18:23040.
  • 45
    Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol. 1997;177:10031010.
  • 46
    Eur Soc Cardiology Task Force. Expert consensus document on management of cardiovascular disease during pregnancy. Eur Heart J. 2003;24:761781.
  • 47
    Iavazzo C, Vitoratos N. Polycystic ovarian syndrome and pregnancy outcome. Arch Gynecol Obstet. 2010;282:235239.
  • 48
    Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy (Cochrane Review). Cochrane Database Syst Rev. 2000;4:CD002863.
  • 49
    Ray JG, Vermeulen MJ, Burrows EA, et al. Use of antihypertensive medications in pregnancy and the risk of adverse perinatal outcomes: McMaster Outcome Study of Hypertension in Pregnancy 2 (MOS HIP 2). BMC Pregnancy Childbirth. 2001;1:613.
  • 50
    Weber MA, Bakris GL, Jamerson K, et al. Cardiovascular events during differing hypertension therapies in patients with diabetes. J Am Coll Cardiol. 2010;56:7785.
  • 51
    Adams EM, Cantab MA, Aberd MD, et al. Long-term effect of pre-eclampsia on blood-pressure. Lancet. 1961;23:13731375.
  • 52
    Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systemic review and meta-analysis. BMJ. 2007;335:974985.
  • 53
    Sandvik MK, Iversen BM, Irgens LM, et al. Are adverse pregnancy outcomes risk factors for development of end-stage renal disease in women with diabetes? Nephrol Dial Transplant. 2010;25:36003607.
  • 54
    Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol. 1986;155:10111016.
  • 55
    Smith GCS, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet. 2001;357:20022006.
  • 56
    Mann JI, Doll R, Thorogood M, et al. Risk factors for myocardial infarction in young women. Br J Prev Soc Med. 1976;30:94100.
  • 57
    Arnadottir GA, Geirsson RT, Arngrimsson R, et al. Cardiovascular death in women who had hypertension in pregnancy: a case-control study. BJOG. 2005;112:286292.
  • 58
    Jonsdottir LS, Arngrimsson R, Geirsson RT, et al. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand. 1995;74:772776.
  • 59
    Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30:s251s2560.
  • 60
    Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care. 2008;31:16681669.
  • 61
    Heitritter SM, Solomon CG, Mitchell GF, et al. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab. 2005;90:39833988.
  • 62
    Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Hypertension. 2003;42:12061252.
  • 63
    Surya P . Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1S22.
  • 64
    Lindheimer MD, Taler SJ, Cunningham FG. ASH position paper: hypertension in pregnancy. J Clin Hypertens (Greenwich). 2009;11:214225.
  • 65
    ACOG. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;99:159167.
  • 66
    Brown MA, Hague WM, Higgins J, et al. The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynaecol. 2000;40:139155.
  • 67
    Helewa ME, Burrows RF, Smith J, et al. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ. 1997;157:715725.